Autoimmune gastritis: comorbid pathology in type 1 diabetes
In recent years noted an increased number of patients with autoimmune diseases (AID), and the special attention deserves combination of several autoimmune pathologies collected in one patient, because such patients requires special tactics of management. Autoimmune diseases of the gastrointestinal t...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN RU |
| Publicado: |
Endocrinology Research Centre
2018
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/ff47cac5d7ca4da1bdadb158e04d4909 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:ff47cac5d7ca4da1bdadb158e04d4909 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:ff47cac5d7ca4da1bdadb158e04d49092021-11-14T09:00:22ZAutoimmune gastritis: comorbid pathology in type 1 diabetes2072-03512072-037810.14341/DM9465https://doaj.org/article/ff47cac5d7ca4da1bdadb158e04d49092018-11-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/9465https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378In recent years noted an increased number of patients with autoimmune diseases (AID), and the special attention deserves combination of several autoimmune pathologies collected in one patient, because such patients requires special tactics of management. Autoimmune diseases of the gastrointestinal tract are less researched and, nevertheless, prognostically unfavorable. Autoimmune gastritis (AIG) has a special place in other stomach diseases, which develops in the aggregate with type 1 diabetes. AIG is a chronic inflammation of the mucous membrane of the body of the stomach, leading to the appearance of atrophy and hypoxecretion. AIG is found in 5–10% of individuals in general population, with a higher incidence of AIG in patients with diabetes and other established autoimmune pathology. AIG is asymptomatic at the early stage of the disease and clinical manifestations appear after the atrophic changes in the mucous membrane of the stomach develop. Since autoimmune gastritis does not have pathognomonic signs, it can manifest itself in hematological and oncological complications at later stages. This is why screening, early diagnosis, prevention and treatment are very important. Early diagnosis and prevention of AIG and its complications play the main role. This article provides an overview of the worldwide data dedicated to this issue.Olga S. DerevyankoLiudmila I. IbragimovaMagomedkerim R. RagimovTatiana V. NikonovaEndocrinology Research Centrearticletype 1 diabetesautoimmune gastritisautoimmune diseasesNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 21, Iss 5, Pp 404-408 (2018) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN RU |
| topic |
type 1 diabetes autoimmune gastritis autoimmune diseases Nutritional diseases. Deficiency diseases RC620-627 |
| spellingShingle |
type 1 diabetes autoimmune gastritis autoimmune diseases Nutritional diseases. Deficiency diseases RC620-627 Olga S. Derevyanko Liudmila I. Ibragimova Magomedkerim R. Ragimov Tatiana V. Nikonova Autoimmune gastritis: comorbid pathology in type 1 diabetes |
| description |
In recent years noted an increased number of patients with autoimmune diseases (AID), and the special attention deserves combination of several autoimmune pathologies collected in one patient, because such patients requires special tactics of management. Autoimmune diseases of the gastrointestinal tract are less researched and, nevertheless, prognostically unfavorable. Autoimmune gastritis (AIG) has a special place in other stomach diseases, which develops in the aggregate with type 1 diabetes. AIG is a chronic inflammation of the mucous membrane of the body of the stomach, leading to the appearance of atrophy and hypoxecretion. AIG is found in 5–10% of individuals in general population, with a higher incidence of AIG in patients with diabetes and other established autoimmune pathology.
AIG is asymptomatic at the early stage of the disease and clinical manifestations appear after the atrophic changes in the mucous membrane of the stomach develop. Since autoimmune gastritis does not have pathognomonic signs, it can manifest itself in hematological and oncological complications at later stages. This is why screening, early diagnosis, prevention and treatment are very important. Early diagnosis and prevention of AIG and its complications play the main role. This article provides an overview of the worldwide data dedicated to this issue. |
| format |
article |
| author |
Olga S. Derevyanko Liudmila I. Ibragimova Magomedkerim R. Ragimov Tatiana V. Nikonova |
| author_facet |
Olga S. Derevyanko Liudmila I. Ibragimova Magomedkerim R. Ragimov Tatiana V. Nikonova |
| author_sort |
Olga S. Derevyanko |
| title |
Autoimmune gastritis: comorbid pathology in type 1 diabetes |
| title_short |
Autoimmune gastritis: comorbid pathology in type 1 diabetes |
| title_full |
Autoimmune gastritis: comorbid pathology in type 1 diabetes |
| title_fullStr |
Autoimmune gastritis: comorbid pathology in type 1 diabetes |
| title_full_unstemmed |
Autoimmune gastritis: comorbid pathology in type 1 diabetes |
| title_sort |
autoimmune gastritis: comorbid pathology in type 1 diabetes |
| publisher |
Endocrinology Research Centre |
| publishDate |
2018 |
| url |
https://doaj.org/article/ff47cac5d7ca4da1bdadb158e04d4909 |
| work_keys_str_mv |
AT olgasderevyanko autoimmunegastritiscomorbidpathologyintype1diabetes AT liudmilaiibragimova autoimmunegastritiscomorbidpathologyintype1diabetes AT magomedkerimrragimov autoimmunegastritiscomorbidpathologyintype1diabetes AT tatianavnikonova autoimmunegastritiscomorbidpathologyintype1diabetes |
| _version_ |
1718429505240956928 |